18.1 C
New York
Saturday, August 2, 2025

Tag: relations

Kuvi.ai Launches Private Beta of Agentic Finance OS with Seed Round Led by Moon Pursuit Capital

Breakthrough Agentic Finance platform makes digital asset transactions as simple as typing a message
Breakthrough Agentic Finance platform makes digital asset transactions as simple as typing a message

Majority of CUPW-represented employees reject Canada Post’s final offers

Corporation evaluating next steps following vote outcome OTTAWA, ON, Aug. 1, 2025 /CNW/ - The Canada Industrial Relations Board (CIRB) has informed Canada Post that a...

Broken Promise: Rate Hikes Guaranteed, Coverage Expansion Dubious, After Lara’s Secretive Model Reviews, says Consumer Watchdog

LOS ANGELES, Aug. 1, 2025 /PRNewswire/ -- Insurance Commissioner Ricardo Lara is breaking his promise to Californians by guaranteeing rate hikes without guaranteeing more coverage,...

PSEG recommends shareholders reject “mini-tender” offer by TRC Capital Investment Corporation

NEWARK, N.J., Aug. 1, 2025 /PRNewswire/ -- Public Service Enterprise Group (NYSE: PEG) today announced that it has received notice of an unsolicited mini-tender offer by...

PIMCO Closed-End Funds Declare Monthly Common Share Distributions

NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) -- The Boards of Trustees/Directors of the PIMCO closed-end funds below (each, a “Fund” and, collectively, the “Funds”) have declared a monthly distribution for each Fund’s common shares as summarized below.

Uniti Completes Merger with Windstream

Intends to Combine Uniti and Windstream Debt Silos Shortly After Merger Closing

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

VANCOUVER, British Columbia and BOSTON, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for patients in need, today announced equity inducement grants to six new non-officer employees consisting of an aggregate of 24,200 share options. All of the foregoing share options were approved by the Compensation Committee of the Company’s Board of Directors with an effective date of July 31, 2025 and were granted as inducements material to the employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4).

AMGEN ANNOUNCES 2025 THIRD QUARTER DIVIDEND

THOUSAND OAKS, Calif., Aug. 1, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $2.38 per share dividend for...

Autoket Rebrands As Supply Veins, Relaunching As An AI-Powered Communications Platform to Revolutionize B2B Procurement Across All Industries

The Supply Veins Co-Founder and CEO is a PenFed Foundation for Military Heroes Veteran Entrepreneur Program Alumnus Multimedia: VIDEO LINK MIAMI, Aug. 1, 2025 /PRNewswire/ -- Autoket,...

Roche’s Susvimo maintains vision over five years with two refills per year in people with neovascular age-related macular degeneration (nAMD)

Basel, 01 August 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today new, five-year efficacy, safety and durability data from the Phase III Portal study, a long-term extension of the Phase III Archway study, of Susvimo® (ranibizumab injection) for the treatment of people with nAMD.1 Results show that Susvimo’s immediate and predictable durability was sustained over five years, with approximately 95% of people receiving treatment every six months requiring no supplemental treatment before each refill. The data were presented at the American Society of Retina Specialists (ASRS) 2025 Annual Meeting in Long Beach, California, United States.

OSR Holdings to Host Virtual Investor Event Providing Key Corporate Updates and Strategic Direction on August 6, 2025

BELLEVUE, Wash., Aug. 1, 2025 /PRNewswire/ -- OSR Holdings, Inc. (NASDAQ: OSRH), a  global healthcare company advancing biomedical innovations to improve health and wellness...

Erayak Power Solution Group Inc. Announces Closing of $7 Million Registered Direct Offering

Wenzhou, China, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Erayak Power Solution Group Inc. (NASDAQ: RAYA) ("Erayak" or the "Company"), a leading manufacturer, designer, and exporter of high-quality products in the power supply industry, today announced the closing of its previously announced registered direct offering with certain institutional investors for the sale and purchase of an aggregate of 107,692,307 of the Company’s  Class A ordinary shares, par value $0.0001 per share (the “Shares”) (or Class A ordinary share equivalents in lieu thereof) in a registered direct offering at a purchase price of $0.065 per share. The purchase price for the pre-funded warrants was $0.065 to the purchase price for Shares, less the exercise price of $0.0001 per share.

Tony Lama Boots Names the Moore Full Quill Ostrich Boot as August Boot of the Month

Premium Materials. Timeless Western Sophistication. FORT WORTH, Texas, Aug. 1, 2025 /PRNewswire/ -- Tony Lama, a name synonymous with fine craftsmanship and Western tradition, has...

CHIPPEWA BOOTS HIGHLIGHTS THUNDERSTRUCK LOGGER WORK BOOT AS AUGUST’S BOOT OF THE MONTH: RUGGED BY NATURE, READY FOR ANYTHING

FORT WORTH, Texas, Aug. 1, 2025 /PRNewswire/ -- Built for those who work hard, explore further, and demand more from their gear, the Thunderstruck...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsRelations